| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Alain L Servin | |
| Vanessa Liévin-Le Moal | |||
| P2860 | cites work | Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin | Q22008776 |
| The MUC3 gene encodes a transmembrane mucin and is alternatively spliced | Q22010259 | ||
| Two novel mucin genes down-regulated in colorectal cancer identified by differential display | Q22010486 | ||
| Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin | Q22010623 | ||
| A Genomic View of the Human-Bacteroides thetaiotaomicron Symbiosis | Q22065827 | ||
| Quorum Sensing in Bacteria | Q22255618 | ||
| Cell-to-cell signalling in Escherichia coli and Salmonella enterica. | Q34319096 | ||
| Microflora of the gastrointestinal tract: a review. | Q34322227 | ||
| Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells | Q34360382 | ||
| Molecular architecture of adherens junctions | Q34360617 | ||
| Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria | Q34378895 | ||
| Human enteric defensins. Gene structure and developmental expression | Q34379039 | ||
| Adhesion of human enterotoxigenic Escherichia coli to human mucus secreting HT-29 cell subpopulations in culture | Q34379824 | ||
| Mucins in the gastrointestinal tract in health and disease | Q34386379 | ||
| Structural organization and classification of the human mucin genes | Q34386462 | ||
| Human enteric defensin genes: chromosomal map position and a model for possible evolutionary relationships | Q34397281 | ||
| Genomics at work: the global gene response to enteric bacteria | Q34400960 | ||
| Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells | Q34407161 | ||
| The indigenous gastrointestinal microflora | Q34409976 | ||
| A molecular view of the intestinal ecosystem. | Q34440247 | ||
| Paneth cells and innate immunity in the crypt microenvironment | Q34444506 | ||
| Molecular structure and assembly of the tight junction. | Q34455527 | ||
| Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity | Q34469853 | ||
| The intestinal epithelial stem cell | Q34488153 | ||
| The multifaceted Paneth cell | Q34531936 | ||
| Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways | Q34532741 | ||
| Cathelicidins--a family of multifunctional antimicrobial peptides. | Q34534231 | ||
| Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements | Q34559453 | ||
| How the gut senses its content. | Q34565124 | ||
| Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity | Q34574499 | ||
| How do bacteria resist human antimicrobial peptides? | Q34575973 | ||
| Regulation of flagellar assembly | Q34588853 | ||
| The bifidobacterial and Lactobacillus microflora of humans | Q34665483 | ||
| Epithelial antimicrobial peptides and proteins: their role in host defence and inflammation | Q34674304 | ||
| How host-microbial interactions shape the nutrient environment of the mammalian intestine | Q34675981 | ||
| Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression | Q34716119 | ||
| Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection | Q34737893 | ||
| Interactions between the microbiota and the intestinal mucosa | Q34763464 | ||
| Adherens junctions: new insight into assembly, modulation and function | Q34811538 | ||
| Intestinal flora during the first months of life: new perspectives. | Q34820480 | ||
| Antagonistic activity of Lactobacillus acidophilus LB against intracellular Salmonella enterica serovar Typhimurium infecting human enterocyte-like Caco-2/TC-7 cells | Q33986792 | ||
| Antibiotic resistance in Salmonella enterica serovar Typhimurium exposed to microcin-producing Escherichia coli | Q33990128 | ||
| Class II antimicrobial peptides from lactic acid bacteria | Q33994632 | ||
| Quorum sensing is a global regulatory mechanism in enterohemorrhagic Escherichia coli O157:H7 | Q33996772 | ||
| Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system | Q34000988 | ||
| Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits | Q34006082 | ||
| Epithelia: not just physical barriers | Q34017925 | ||
| Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease | Q34032146 | ||
| Tight junction, a platform for trafficking and signaling protein complexes | Q34086502 | ||
| Ultrastructure of Paneth cells in the intestine of various mammals | Q34088289 | ||
| A Lactobacillus acidophilus strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica Serovar Typhimurium by triggering lethal bacterial membrane damage | Q34097875 | ||
| pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium | Q34098013 | ||
| MUC17, a novel membrane-tethered mucin. | Q34115097 | ||
| Paneth cell trypsin is the processing enzyme for human defensin-5. | Q34129474 | ||
| Molecular assessment of intestinal microflora | Q34130926 | ||
| Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive | Q34137381 | ||
| Structure and function of Toll-like receptor proteins | Q34146916 | ||
| Human MUC1 mucin: a multifaceted glycoprotein. | Q34147898 | ||
| Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways | Q34155054 | ||
| The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota | Q34156291 | ||
| Paneth cell defensins and innate immunity of the small bowel | Q34171943 | ||
| Signalling to and from tight junctions | Q34180670 | ||
| Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin | Q34186394 | ||
| How Bacteria Assemble Flagella | Q34194719 | ||
| NODs: intracellular proteins involved in inflammation and apoptosis | Q34199862 | ||
| Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. | Q34200002 | ||
| Lantibiotics: structure, biosynthesis and mode of action | Q34248859 | ||
| Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. | Q34274121 | ||
| Bacterial colonization leads to the colonic secretion of RELMβ/FIZZ2, a novel goblet cell-specific protein | Q34274465 | ||
| Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. | Q34292705 | ||
| Trypsin mediates growth phase-dependent transcriptional tegulation of genes involved in biosynthesis of ruminococcin A, a lantibiotic produced by a Ruminococcus gnavus strain from a human intestinal microbiota | Q34304204 | ||
| MEF up-regulates human beta-defensin 2 expression in epithelial cells. | Q34304777 | ||
| Bacterial invasion: the paradigms of enteroinvasive pathogens | Q34312229 | ||
| Antimicrobial peptides (AMPs): peptide structure and mode of action | Q36275702 | ||
| Bacterial exposure induces and activates matrilysin in mucosal epithelial cells | Q36326278 | ||
| A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem | Q36436689 | ||
| Quorum sensing in Escherichia coli and Salmonella typhimurium. | Q36507025 | ||
| Quorum sensing controls expression of the type III secretion gene transcription and protein secretion in enterohemorrhagic and enteropathogenic Escherichia coli | Q36783792 | ||
| Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. | Q36852656 | ||
| Structure, function and gene expression of epithelial mucins. | Q36878241 | ||
| Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. | Q36899142 | ||
| Invasion by Salmonella typhimurium is affected by the direction of flagellar rotation | Q36946395 | ||
| Salmonella typhimurium mutants lacking flagella or motility remain virulent in BALB/c mice | Q36975775 | ||
| Cholera enterotoxin-induced mucus secretion and increase in the mucus blanket of the rabbit ileum in vivo | Q37000648 | ||
| Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity | Q37368468 | ||
| Large-scale population structure of human commensal Escherichia coli isolates | Q37553049 | ||
| Intestinal defensin gene expression in human populations. | Q38971813 | ||
| Gangliosides act as co-receptors for Salmonella enteritidis FliC and promote FliC induction of human beta-defensin-2 expression in Caco-2 cells | Q39318238 | ||
| Antibacterial activity evaluation of microcin J25 against diarrheagenic Escherichia coli | Q39488077 | ||
| Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. | Q39512909 | ||
| Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology | Q39523461 | ||
| Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS. | Q39557331 | ||
| Helicobacter pylori-mediated transcriptional regulation of the human beta-defensin 2 gene requires NF-kappaB. | Q39567005 | ||
| Listeria monocytogenes stimulates mucus exocytosis in cultured human polarized mucosecreting intestinal cells through action of listeriolysin O. | Q39572243 | ||
| Mucin exocytosis: a major target for Helicobacter pylori | Q39610750 | ||
| Helicobacter pylori uses motility for initial colonization and to attain robust infection | Q39654398 | ||
| Quorum-sensing Escherichia coli regulator A: a regulator of the LysR family involved in the regulation of the locus of enterocyte effacement pathogenicity island in enterohemorrhagic E. coli. | Q39655068 | ||
| The Afa/Dr adhesins of diffusely adhering Escherichia coli stimulate interleukin-8 secretion, activate mitogen-activated protein kinases, and promote polymorphonuclear transepithelial migration in T84 polarized epithelial cells | Q39730178 | ||
| PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance | Q39843622 | ||
| Microcin 15m from Escherichia coli: mechanism of antibiotic action | Q39856613 | ||
| Canonical Wnt signals are essential for homeostasis of the intestinal epithelium | Q39895829 | ||
| Mucin degradation mechanisms by distinct Pseudomonas aeruginosa isolates in vitro. | Q39912942 | ||
| Microcin 25, a novel antimicrobial peptide produced by Escherichia coli | Q39939774 | ||
| Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells | Q39955901 | ||
| NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. | Q40017434 | ||
| Binding of Yersinia enterocolitica to rabbit intestinal brush border membranes, mucus, and mucin | Q40159854 | ||
| Novel effects of the prototype translocating Escherichia coli, strain C25 on intestinal epithelial structure and barrier function | Q40347391 | ||
| Mucin gene structure and expression: protection vs. adhesion | Q40377654 | ||
| The increase in mucin exocytosis and the upregulation of MUC genes encoding for membrane-bound mucins induced by the thiol-activated exotoxin listeriolysin O is a host cell defence response that inhibits the cell-entry of Listeria monocytogenes | Q40410400 | ||
| Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells | Q40414006 | ||
| Cathelicidins: a novel protein family with a common proregion and a variable C‐terminal antimicrobial domain | Q40432691 | ||
| Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. | Q40450359 | ||
| Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells | Q41011699 | ||
| Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. | Q41033205 | ||
| Human mucin genes MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express stable and extremely large mRNAs and exhibit a variable length polymorphism. An improved method to analyze large mRNAs | Q41066090 | ||
| Neurotensin and neuromedin N stimulate mucin output from human goblet cells (Cl.16E) via neurotensin receptors | Q41083074 | ||
| Purinergic agonists, but not cAMP, stimulate coupled granule fusion and Cl- conductance in HT29-Cl.16E. | Q41088569 | ||
| Early functional effects of Clostridium difficile toxin A on human colonocytes | Q41108206 | ||
| The trefoil peptide family | Q41117683 | ||
| Differential stimulation of intestinal mucin secretion by cholera toxin and carbachol | Q41125651 | ||
| Recent aspects of the regulation of intestinal mucus secretion | Q41131954 | ||
| Paneth cell defensins: endogenous peptide components of intestinal host defense | Q41135366 | ||
| Recruitment of purinergically stimulated Cl- channels from granule membrane to plasma membrane | Q41180211 | ||
| Differentiation-associated antimicrobial functions in human colon adenocarcinoma cell lines | Q41185478 | ||
| Direct secretory effect of interleukin-1 via type I receptors in human colonic mucous epithelial cells (HT29-C1.16E). | Q41231557 | ||
| Ca2+ and cAMP activate different K+ conductances in the human intestinal goblet cell line HT29-Cl.16E | Q41340947 | ||
| Cyclic AMP-induced mucin exocytosis is independent of Cl- movements in human colonic epithelial cells (HT29-Cl.16E). | Q41410834 | ||
| Role of calcium in carbachol- and neurotensin-induced mucin exocytosis in a human colonic goblet cell line and cross-talk with the cyclic AMP pathway | Q41473745 | ||
| ATP-stimulated electrolyte and mucin secretion in the human intestinal goblet cell line HT29-Cl.16E. | Q41501275 | ||
| Adhering heat-killed human Lactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrhoeagenic bacteria in cultured human intestinal cells | Q41501382 | ||
| Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion | Q41502745 | ||
| Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus | Q41634513 | ||
| A 450-kb contig of defensin genes on human chromosome 8p23. | Q41673770 | ||
| Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. | Q41705704 | ||
| Molecular architecture of tight junctions | Q41748256 | ||
| Interaction of cholera toxin with cloned human goblet cells in monolayer culture | Q41753254 | ||
| Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures | Q42018332 | ||
| Histochemistry of the surface mucous gel layer of the human colon | Q42130607 | ||
| Paneth cells and antibacterial host defense in neonatal small intestine | Q42148628 | ||
| Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity | Q42158764 | ||
| Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. | Q42161372 | ||
| Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro | Q42282244 | ||
| The regulation of human beta-defensin 2 by the ETS transcription factor MEF (myeloid Elf-1-like factor) is enhanced by promyelocytic leukemia protein | Q42465603 | ||
| Functional VIP receptors in the human mucus-secreting colonic epithelial cell line CL.16E. | Q42492689 | ||
| Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins | Q42522378 | ||
| A model of host-microbial interactions in an open mammalian ecosystem | Q42634168 | ||
| Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli. | Q42673580 | ||
| Human beta-defensin-1: A urinary peptide present in variant molecular forms and its putative functional implication | Q42827761 | ||
| Respiratory mucins: identification of core proteins and glycoforms | Q42982717 | ||
| H pylori colocalises with MUC5AC in the human stomach | Q43086435 | ||
| Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease | Q43566703 | ||
| Bacterial modification of LPS and resistance to antimicrobial peptides | Q43718689 | ||
| Antagonistic activity of Lactobacillus casei strain shirota against gastrointestinal Listeria monocytogenes infection in rats | Q43910008 | ||
| Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability | Q43930057 | ||
| beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime | Q44218603 | ||
| Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. | Q44254786 | ||
| Normal human conjunctival epithelium expresses MUC13, MUC15, MUC16 and MUC17 mucin genes | Q44536629 | ||
| Antimicrobial peptides are among the antagonistic metabolites produced by Bifidobacterium against Helicobacter pylori | Q44596850 | ||
| H. pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase | Q44627335 | ||
| Effects of microcin 24-producing Escherichia coli on shedding and multiple-antimicrobial resistance of Salmonella enterica serotype typhimurium in pigs | Q45210691 | ||
| Murine intestinal mucins inhibit rotavirus infection. | Q46038651 | ||
| Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. | Q46266208 | ||
| Maternal adaptive immunity influences the intestinal microflora of suckling mice | Q46336227 | ||
| Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori | Q46571686 | ||
| Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8. | Q46809881 | ||
| Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. | Q47275919 | ||
| Inhibition of Salmonella enterica serovars by microcin J25. | Q47304615 | ||
| Transcriptional control of the antimicrobial peptide resistance ugtL gene by the Salmonella PhoP and SlyA regulatory proteins | Q47316351 | ||
| Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria | Q47962035 | ||
| Use of bacteriocin promoters for gene expression in Lactobacillus plantarum C11. | Q47973273 | ||
| PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance | Q48038471 | ||
| Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ. | Q50091911 | ||
| Flagella-mediated bacterial motility accelerates but is not required for Salmonella serotype Enteritidis invasion of differentiated Caco-2 cells | Q50094605 | ||
| Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces | Q31004928 | ||
| Resistance to host antimicrobial peptides is necessary for Salmonella virulence | Q31030619 | ||
| PhoP-regulated Salmonella resistance to the antimicrobial peptides magainin 2 and polymyxin B. | Q31085117 | ||
| Microcin E492 antibacterial activity: evidence for a TonB-dependent inner membrane permeabilization on Escherichia coli | Q31151217 | ||
| Does Helicobacter pylori affect gastric mucin expression? Relationship between gastric antral mucin expression and H. pylori colonization | Q32010545 | ||
| Lactobacillus acidophilus (strain LB) from the resident adult human gastrointestinal microflora exerts activity against brush border damage promoted by a diarrhoeagenic Escherichia coli in human enterocyte-like cells | Q32109047 | ||
| Development of the human gastrointestinal tract: twenty years of progress | Q33535761 | ||
| Developmental microbial ecology of the neonatal gastrointestinal tract | Q33610632 | ||
| Influences of microbiota on intestinal immune system development | Q33610638 | ||
| Antimicrobial peptides as mediators of epithelial host defense | Q33657838 | ||
| M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process | Q33669591 | ||
| IV. Paneth cell antimicrobial peptides and the biology of the mucosal barrier. | Q33709901 | ||
| Comprehensive study of the intestinal stage of listeriosis in a rat ligated ileal loop system. | Q33750545 | ||
| The structure and assembly of secreted mucins | Q33763293 | ||
| Defensins and innate host defence of the gastrointestinal tract | Q33774141 | ||
| Analyzing the molecular foundations of commensalism in the mouse intestine | Q33840574 | ||
| Stem cells: the intestinal stem cell as a paradigm. | Q33846215 | ||
| Bacterial regulation of intestinal immune responses | Q33930753 | ||
| Gut instincts: thoughts on intestinal epithelial stem cells | Q33936387 | ||
| Glycans as legislators of host-microbial interactions: spanning the spectrum from symbiosis to pathogenicity | Q33941416 | ||
| Collaboration of epithelial cells with organized mucosal lymphoid tissues. | Q33955758 | ||
| Structure and biology of cathelicidins | Q33970134 | ||
| Anoikis | Q33978500 | ||
| Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection | Q33982279 | ||
| Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers | Q33985774 | ||
| Commensal host-bacterial relationships in the gut | Q28188763 | ||
| Antimicrobial and Protease Inhibitory Functions of the Human Cathelicidin (hCAP18/LL-37) Prosequence | Q28201013 | ||
| Defensins: antimicrobial peptides of innate immunity | Q28204453 | ||
| Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction | Q28204611 | ||
| Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria | Q28204776 | ||
| Cathelicidins, multifunctional peptides of the innate immunity | Q28205494 | ||
| Production of beta-defensin-2 by human colonic epithelial cells induced by Salmonella enteritidis flagella filament structural protein | Q28208128 | ||
| Multifunctional strands in tight junctions | Q28210051 | ||
| Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression | Q28211358 | ||
| Cathelicidins: a family of endogenous antimicrobial peptides | Q28213120 | ||
| Anoikis mechanisms | Q28215553 | ||
| Mucins in cancer: protection and control of the cell surface | Q28235006 | ||
| A peptide antibiotic from human skin | Q28242199 | ||
| The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry | Q28247017 | ||
| Antimicrobial polypeptides of the human colonic epithelium | Q28250179 | ||
| MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis | Q28291183 | ||
| hBD-1: a novel beta-defensin from human plasma | Q28294850 | ||
| Innate immunity and the normal microflora | Q28373296 | ||
| Increased diversity of intestinal antimicrobial peptides by covalent dimer formation | Q28505962 | ||
| Extracellular regulated kinase (ERK)-dependent regulation of sialomucin complex/rat Muc4 in mammary epithelial cells | Q28564603 | ||
| Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract | Q28587612 | ||
| Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4 | Q28592260 | ||
| Wnt signalling induces maturation of Paneth cells in intestinal crypts | Q28593773 | ||
| Defensins: endogenous antibiotic peptides from human leukocytes | Q28612115 | ||
| Molecular analysis of commensal host-microbial relationships in the intestine | Q29614776 | ||
| Toll-like receptors and innate immunity | Q29615458 | ||
| Interactions between commensal intestinal bacteria and the immune system | Q29617039 | ||
| Linking colorectal cancer to Wnt signaling | Q29619810 | ||
| The MUC family: an obituary. | Q30329963 | ||
| Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells | Q30476839 | ||
| The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession | Q30666032 | ||
| Focus on modified microcins: structural features and mechanisms of action | Q30869207 | ||
| Thermolysin-linearized microcin J25 retains the structured core of the native macrocyclic peptide and displays antimicrobial activity | Q30873433 | ||
| Germ-free and colonized mice generate the same products from enteric prodefensins | Q30931828 | ||
| In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli | Q31004513 | ||
| Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins | Q35737867 | ||
| Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system | Q35742370 | ||
| Defensin-mediated innate immunity in the small intestine | Q35762898 | ||
| The tight junction: a multifunctional complex | Q35777543 | ||
| Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease | Q35781073 | ||
| Signalling mechanisms of anoikis | Q35787408 | ||
| The role of Paneth cells and their antimicrobial peptides in innate host defense. | Q35847082 | ||
| Quorum sensing control of lantibiotic production; nisin and subtilin autoregulate their own biosynthesis | Q35890674 | ||
| Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens | Q35890738 | ||
| The role of Toll-like receptors and Nod proteins in bacterial infection | Q35914426 | ||
| Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions | Q35962003 | ||
| Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease | Q35967062 | ||
| Adherence of diarrheagenic Escherichia coli strains to epithelial cells. | Q35993185 | ||
| Membrane interactions of host-defense peptides studied in model systems. | Q36002916 | ||
| Who's talking to whom? Epithelial-bacterial pathogen interactions. | Q36015003 | ||
| Defensins and mucosal protection. | Q36019624 | ||
| Compartmentalization of the mucosal immune responses to commensal intestinal bacteria | Q36024753 | ||
| Cell and molecular biology of the small intestine: new insights into differentiation, growth and repair. | Q36036420 | ||
| The Paneth cell and the innate immune response | Q36036656 | ||
| Recent findings in the cell and molecular biology of the small intestine | Q36041921 | ||
| Defence molecules in intestinal innate immunity against bacterial infections | Q36041934 | ||
| Wnt, stem cells and cancer in the intestine | Q36044404 | ||
| Organization of vesicular trafficking in epithelia | Q36058478 | ||
| Defensins and cathelicidins: neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis. | Q36077370 | ||
| Human defensins | Q36094398 | ||
| Intestinal microbiota | Q36095198 | ||
| Bacterial modulation of mucosal innate immunity | Q36097463 | ||
| Innate immune defence in the human gastrointestinal tract. | Q36097469 | ||
| Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria | Q36122642 | ||
| Defensins and other antimicrobial peptides: a historical perspective and an update | Q36126577 | ||
| Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics | Q36126588 | ||
| Commensal gut bacteria: mechanisms of immune modulation | Q36143433 | ||
| Regulation of mammalian defensin expression by Toll-like receptor-dependent and independent signalling pathways | Q36253626 | ||
| Microbial ecology of the gastrointestinal tract | Q22255628 | ||
| Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic | Q24290539 | ||
| Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells | Q24291012 | ||
| Angiogenins: a new class of microbicidal proteins involved in innate immunity | Q24293270 | ||
| Antimicrobial peptides in the first line defence of human colon mucosa | Q24308002 | ||
| Myeloid Elf-1-like factor, an ETS transcription factor, up-regulates lysozyme transcription in epithelial cells through interaction with promyelocytic leukemia protein | Q24310252 | ||
| The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells | Q24314491 | ||
| Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion | Q24322937 | ||
| Intracellular vs extracellular recognition of pathogens--common concepts in mammals and flies | Q24498417 | ||
| Human mucin gene MUC4: organization of its 5'-region and polymorphism of its central tandem repeat array | Q24530913 | ||
| Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium | Q24537181 | ||
| Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917 | Q24561803 | ||
| Defensins. Natural peptide antibiotics of human neutrophils | Q24563852 | ||
| Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung | Q24564556 | ||
| Toll-like receptor signalling | Q24570126 | ||
| Mucins and inflammatory bowel disease | Q24669634 | ||
| Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection | Q24669669 | ||
| Localization of human intestinal defensin 5 in Paneth cell granules | Q24674859 | ||
| Antimicrobial substance from a human Lactobacillus strain | Q24676914 | ||
| Toll-like receptor downstream signaling | Q24799256 | ||
| Innate immune recognition | Q27860721 | ||
| Notch signaling: cell fate control and signal integration in development | Q27861061 | ||
| Human beta-defensin-2 | Q28139532 | ||
| Epithelial M cells: differentiation and function | Q28141133 | ||
| Antimicrobial peptides of lactic acid bacteria: mode of action, genetics and biosynthesis | Q28141541 | ||
| Abundant human beta-defensin-1 expression in milk and mammary gland epithelium | Q28142157 | ||
| Toll-like receptors in the induction of the innate immune response | Q28144797 | ||
| Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense | Q28145389 | ||
| Intestinal microflora in early infancy: composition and development | Q28181875 | ||
| Mucin and Toll-like receptors in host defense against intestinal parasites | Q28186441 | ||
| Sp1 is involved in the transcriptional activation of lysozyme in epithelial cells. | Q40500121 | ||
| In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain | Q40526966 | ||
| Enteroaggregative Escherichia coli flagellin-induced interleukin-8 secretion requires Toll-like receptor 5-dependent p38 MAP kinase activation | Q40532416 | ||
| Signal transduction, packaging and secretion of mucins | Q40543271 | ||
| Epithelial mucin genes | Q40543275 | ||
| Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport | Q40557124 | ||
| The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens | Q40574865 | ||
| Induction of plantaricin production in Lactobacillus plantarum NC8 after coculture with specific gram-positive bacteria is mediated by an autoinduction mechanism | Q40584967 | ||
| Membrane ruffling and invasion of human and avian cell lines is reduced for aflagellate mutants of Salmonella enterica serotype Enteritidis | Q40632610 | ||
| LPS up-regulates mucin and cytokine mRNA expression and stimulates mucin and cytokine secretion in goblet cells | Q40648497 | ||
| CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells | Q40659073 | ||
| Human serum amyloid A3 peptide enhances intestinal MUC3 expression and inhibits EPEC adherence. | Q40680713 | ||
| Human beta-defensin-2 induction in Helicobacter pylori-infected gastric mucosal tissues: antimicrobial effect of overexpression | Q40682731 | ||
| Activation of mucin exocytosis and upregulation of MUC genes in polarized human intestinal mucin-secreting cells by the thiol-activated exotoxin listeriolysin O. | Q40711330 | ||
| Modulation of host antimicrobial peptide (beta-defensins 1 and 2) expression during gastritis. | Q40711507 | ||
| The structure and regulation of tight junctions | Q40780311 | ||
| Characterization of human mucin gene MUC4 promoter: importance of growth factors and proinflammatory cytokines for its regulation in pancreatic cancer cells. | Q40797367 | ||
| A heat labile soluble factor from Bacteroides thetaiotaomicron VPI-5482 specifically increases the galactosylation pattern of HT29-MTX cells | Q40813269 | ||
| Listeriolysin O-induced stimulation of mucin exocytosis in polarized intestinal mucin-secreting cells: evidence for toxin recognition of membrane-associated lipids and subsequent toxin internalization through caveolae | Q40826465 | ||
| Genetics of bacteriocins produced by lactic acid bacteria | Q40858745 | ||
| Tight junctions are membrane microdomains | Q40886204 | ||
| Physical characterization of the MUC5AC mucin: a highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions | Q40892367 | ||
| Induction of human beta-defensin-2 mRNA expression by Helicobacter pylori in human gastric cell line MKN45 cells on cag pathogenicity island | Q40924698 | ||
| Fimbriae- and flagella-mediated association with and invasion of cultured epithelial cells by Salmonella enteritidis | Q40946895 | ||
| Purinergic and cholinergic agonists induce exocytosis from the same granule pool in HT29-Cl.16E monolayers. | Q40961386 | ||
| Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. | Q40961532 | ||
| Human mucin glycoproteins: varied structures predict diverse properties and specific functions | Q41001407 | ||
| Regulation of mucin exocytosis from intestinal goblet cells | Q41001426 | ||
| Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells | Q34853145 | ||
| Bacteriocin diversity: ecological and evolutionary perspectives | Q34992663 | ||
| The regulation of microcin B, C and J operons. | Q34992710 | ||
| Cell to cell communication by autoinducing peptides in gram-positive bacteria | Q35007700 | ||
| Cell signaling through membrane mucins | Q35036941 | ||
| The functions of mucosal T cells in containing the indigenous commensal flora of the intestine | Q35060048 | ||
| Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium | Q35107765 | ||
| Microbial pathogenesis and cytoskeletal function. | Q35109715 | ||
| Intestinal M cells and their role in bacterial infection | Q35130619 | ||
| Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB | Q35136011 | ||
| Functional analysis of tight junctions | Q35150365 | ||
| Quorum sensing and expression of virulence in Escherichia coli O157:H7. | Q35156090 | ||
| Pathological interactions of bacteria and toxins with the gastrointestinal epithelial tight junctions and/or the zonula adherens: an update. | Q35168453 | ||
| Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans. | Q35196131 | ||
| The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo | Q35202986 | ||
| Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity | Q35361878 | ||
| Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease | Q35362664 | ||
| Expression of human beta-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori | Q35365183 | ||
| Mucin gene expression in intestinal epithelial cells in Crohn's disease | Q35365318 | ||
| Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria? | Q35540646 | ||
| Bacteroides thetaiotaomicron: a dynamic, niche‐adapted human symbiont | Q35541301 | ||
| Bacterial pathogenesis: exploiting cellular adherence | Q35547387 | ||
| Broad-spectrum antimicrobial activity of human intestinal defensin 5. | Q35549706 | ||
| Role of Toll-like receptors in pathogen recognition. | Q35558810 | ||
| α-Defensins in the gastrointestinal tract | Q35563987 | ||
| Cathelicidin family of antimicrobial peptides: proteolytic processing and protease resistance | Q35582184 | ||
| Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features | Q35586790 | ||
| Interaction between resident luminal bacteria and the host: can a healthy relationship turn sour? | Q35634287 | ||
| The differentiating intestinal epithelial cell: establishment and maintenance of functions through interactions between cellular structures | Q35651713 | ||
| Trypsin-dependent production of an antibacterial substance by a human Peptostreptococcus strain in gnotobiotic rats and in vitro | Q35681748 | ||
| Mucins and mucin binding proteins in colorectal cancer | Q35682100 | ||
| Innate immunity via Toll-like receptors and Nod proteins | Q35702964 | ||
| Cell-to-cell signaling in intestinal pathogens. | Q35728492 | ||
| Abnormal Paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice | Q50101740 | ||
| Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. | Q50101913 | ||
| Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. | Q50102772 | ||
| Lack of flagella disadvantages Salmonella enterica serovar Enteritidis during the early stages of infection in the rat. | Q50106162 | ||
| Contribution of flagella and invasion proteins to pathogenesis of Salmonella enterica serovar enteritidis in chicks | Q50112117 | ||
| The antibacterial action of microcin J25: evidence for disruption of cytoplasmic membrane energization in Salmonella newport | Q50112123 | ||
| Salmonella enteritidis FliC (flagella filament protein) induces human beta-defensin-2 mRNA production by Caco-2 cells | Q50115124 | ||
| Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: I kappa B alpha degradation, induction of nitric oxide synthase, induction of proinflammatory mediators, and cardiovascular dysfunction | Q50117610 | ||
| Adhesion of Salmonella enterica var Enteritidis strains lacking fimbriae and flagella to rat ileal explants cultured at the air interface or submerged in tissue culture medium | Q50119948 | ||
| Inactivation of the flagellin gene of Salmonella enterica serotype enteritidis strongly reduces invasion into differentiated Caco-2 cells | Q50121609 | ||
| Intestinal mucins: the binding sites for Salmonella typhimurium | Q50122010 | ||
| Inhibition of pathogenic Salmonella enteritidis growth mediated by Escherichia coli microcin J25 producing strains | Q50122214 | ||
| Purification and primary structure of murine cryptdin-1, a Paneth cell defensin | Q50176329 | ||
| Role of 5-HT in cholera toxin-induced mucin secretion in the rat small intestine. | Q51569667 | ||
| Neural mediation of cholera toxin-induced mucin secretion in the rat small intestine. | Q51648604 | ||
| Intestinal epithelial-mesenchymal cell interactions. | Q52179995 | ||
| Variation in human intestinal microbiota with age. | Q53953828 | ||
| Identification of a Clostridium cocleatum strain involved in an anti-Clostridium difficile barrier effect and determination of its mucin-degrading enzymes. | Q54240074 | ||
| Taxonomic Lactobacillus Composition of Feces from Human Newborns during the First Few Days | Q54306254 | ||
| [Transfer of the cecal flora of the hamster to the germfree C3H mouse: use of this model to study the flora of the anti-Clostridium difficile barrier] | Q54433308 | ||
| Enteropathogenic Escherichia coli (EPEC) effector-mediated suppression of antimicrobial nitric oxide production in a small intestinal epithelial model system. | Q54474693 | ||
| Penetration and interactions of the antimicrobial peptide, microcin J25, into uncharged phospholipid monolayers. | Q54488890 | ||
| Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease. | Q54522199 | ||
| Bifidobacterium cell wall proteins induced beta-defensin 2 mRNA expression in human intestinal epithelial cells | Q54568547 | ||
| Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli. | Q54638065 | ||
| Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. | Q54656237 | ||
| A New Monoclonal Antibody Demonstrates That Muc4, the Intramembrane Ligand for Erbb2/Her2/Neu, Is Overexpressed in Multiple Carcinomas. | Q55436393 | ||
| Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator | Q57940216 | ||
| Tight junction proteins1This review is dedicated to the memory of Thomas Kreis.1 | Q58098084 | ||
| The Essential Role of the Intestinal Microbiota in Facilitating Acute Inflammatory Responses | Q58227634 | ||
| MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence | Q58454736 | ||
| Notch signals control the fate of immature progenitor cells in the intestine | Q59048442 | ||
| Pro-inflammatory Cytokines Up-regulate MUC1 Gene Expression in Oral Epithelial Cells | Q59790040 | ||
| Crowd control: quorum sensing in pathogenic E. coli | Q60584791 | ||
| SdiA, an Escherichia coli homologue of quorum-sensing regulators, controls the expression of virulence factors in enterohaemorrhagic Escherichia coli O157:H7 | Q61857106 | ||
| Epithelial inflammation response induced by Shigella flexneri depends on mucin gene expression | Q62660208 | ||
| Separation of cholera enterotoxin-induced mucus secretion from electrolyte secretion in rabbit ileum by acetazolamide, colchicine, cycloheximide, cytochalasin B and indomethacin | Q71067315 | ||
| Human mucin genes: genomic organization and expression of MUC4, MUC5AC and MUC5B | Q71130718 | ||
| Bacteriocins of gram-positive bacteria | Q71852767 | ||
| Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis | Q78766823 | ||
| The MUC5AC Glycoprotein is the Primary Receptor for Helicobacter pylori in the Human Stomach | Q79137100 | ||
| Host anti-microbial response to Helicobacter pylori infection | Q79185625 | ||
| Cholera-induced mucin secretion from rat intestine: lack of effect of cAMP, cycloheximide, VIP, and colchicine | Q72388101 | ||
| Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat | Q72718175 | ||
| Protein kinase-A-mediated secretion of mucin from human colonic epithelial cells | Q73134393 | ||
| [In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains] | Q73249368 | ||
| Antimicrobial activity of a 14-residue peptide against Escherichia coli O157:H7 | Q73265313 | ||
| Colonic mucin discharge by a cholinergic agonist, prostaglandins, and peptide YY in the isolated vascularly perfused rat colon | Q73325652 | ||
| Muc1 mucins on the cell surface are adhesion sites for Pseudomonas aeruginosa | Q73335460 | ||
| Food supplementation with milk fermented by Lactobacillus casei DN-114 001 protects suckling rats from rotavirus-associated diarrhea | Q73513787 | ||
| Inhibition of gastric mucin synthesis by Helicobacter pylori | Q73838428 | ||
| A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria | Q73919528 | ||
| Action of antimicrobial peptides: two-state model | Q74061744 | ||
| Binding of enterotoxigenic Escherichia coli to isolated enterocytes and intestinal mucus | Q74088224 | ||
| Identification of genes involved in mucosal defense and inflammation associated with normal enteric bacteria | Q74227983 | ||
| Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics | Q74418719 | ||
| Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis | Q74428266 | ||
| Binding of Shigella to rat and human intestinal mucin | Q74453058 | ||
| Inhibition of in vitro growth of Shiga toxin-producing Escherichia coli O157:H7 by probiotic Lactobacillus strains due to production of lactic acid | Q74483659 | ||
| Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease | Q74593708 | ||
| Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem | Q74626882 | ||
| Microbial-host interactions specifically control the glycosylation pattern in intestinal mouse mucosa | Q74634379 | ||
| Colonization of microflora in mice: mucosal defense against luminal bacteria | Q77329043 | ||
| Studying M cells and their role in infection | Q77432410 | ||
| [Physiology of microflora in the digestive tract] | Q77654426 | ||
| Nitric oxide: a regulator of mucosal defense and injury | Q77683588 | ||
| The intestinal microflora regulates cytokine production positively in spleen-derived macrophages but negatively in bone marrow-derived macrophages | Q78224116 | ||
| Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection | Q78293150 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antimicrobial peptide | Q1201508 |
| P304 | page(s) | 315-337 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | Clinical Microbiology Reviews | Q5133777 |
| P1476 | title | The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota | |
| P478 | volume | 19 |
| Q42143630 | A role for antimicrobial peptides in intestinal microsporidiosis |
| Q41328596 | Adhesion of Lactobacilli and their anti-infectivity potential |
| Q40202753 | Aeromonas salmonicida Growth in Response to Atlantic Salmon Mucins Differs between Epithelial Sites, Is Governed by Sialylated and N-Acetylhexosamine-Containing O-Glycans, and Is Affected by Ca2. |
| Q37661325 | Allograft inflammatory factor 1 is a regulator of transcytosis in M cells |
| Q93197494 | Altered Caecal Neuroimmune Interactions in the Neuroligin-3R451C Mouse Model of Autism |
| Q37518736 | Amphibian gut microbiota shifts differentially in community structure but converges on habitat-specific predicted functions. |
| Q37097646 | Animal models of enteroaggregative Escherichia coli infection |
| Q33352702 | Anti-fungal innate immunity in C. elegans is enhanced by evolutionary diversification of antimicrobial peptides |
| Q37712802 | Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents |
| Q34987870 | Antimicrobial peptides and gut microbiota in homeostasis and pathology. |
| Q36692352 | Application of Scutellariae radix, Gardeniae fructus, and Probiotics to Prevent Salmonella enterica Serovar Choleraesuis Infection in Swine |
| Q35087604 | Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis |
| Q58777471 | Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer |
| Q36049714 | Bacillus clausii and gut homeostasis: state of the art and future perspectives. |
| Q42324273 | Bacillus subtilis biofilm extends Caenorhabditis elegans longevity through downregulation of the insulin-like signalling pathway |
| Q34030624 | Back to the future: studying cholera pathogenesis using infant rabbits |
| Q38254145 | Bacterial colonization and intestinal mucosal barrier development |
| Q55070889 | Biomechanical aspects of the auto-digestion theory. |
| Q36792480 | Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model |
| Q37122290 | Cardiolipins Act as a Selective Barrier to Toll-Like Receptor 4 Activation in the Intestine. |
| Q46664775 | Cellular cross talk in the small intestinal mucosa: postnatal lymphocytic immigration elicits a specific epithelial transcriptional response |
| Q33612677 | Chemical and pathogen-induced inflammation disrupt the murine intestinal microbiome |
| Q47313645 | Chitin protects gut epithelial barrier in a protochordate model of DSS-induced colitis. |
| Q36834812 | Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper |
| Q38747097 | Clinical implications of antibiotic impact on gastrointestinal microbiota and Clostridium difficile Infection |
| Q38128618 | Commensal Clostridia: leading players in the maintenance of gut homeostasis. |
| Q34407355 | Complementary symbiont contributions to plant decomposition in a fungus-farming termite. |
| Q36163146 | Critical roles of Notch and Wnt/β-catenin pathways in the regulation of hyperplasia and/or colitis in response to bacterial infection |
| Q90745225 | Current Developments in the Immunology of Psoriasis |
| Q37228730 | Design and activity of a 'dual-targeted' antimicrobial peptide |
| Q36775698 | Differential DNA methylation patterns of homeobox genes in proximal and distal colon epithelial cells. |
| Q27313965 | Distinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureus |
| Q36799601 | Dry eye disease and microbial keratitis: is there a connection? |
| Q38084328 | Dysfunctions at human intestinal barrier by water-borne protozoan parasites: lessons from cultured human fully differentiated colon cancer cell lines |
| Q50589903 | Early intestinal growth and development in poultry. |
| Q52873630 | Effect of dietary zinc oxide on jejunal morphological and immunological characteristics in weaned piglets. |
| Q57984341 | Effect of multifibre mixture with prebiotic components on bifidobacteria and stool pH in tube-fed children |
| Q41187148 | Effect of various fiber types and choice feeding of fiber on performance, gut development, humoral immunity, and fiber preference in broiler chicks. |
| Q35605686 | Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection |
| Q90138759 | Effects of dietary fiber and threonine on performance, intestinal morphology and immune responses in broiler chickens |
| Q42121668 | Enhancement of Shiga toxin production in enterohemorrhagic Escherichia coli serotype O157:H7 by DNase colicins |
| Q42119561 | Enterohemorrhagic Escherichia coli O157:H7 survival in an in vitro model of the human large intestine and interactions with probiotic yeasts and resident microbiota |
| Q41433037 | Enteropathogenic Escherichia coli, Samonella, Shigella and Yersinia: cellular aspects of host-bacteria interactions in enteric diseases |
| Q35941241 | Epithelium-Intrinsic MicroRNAs Contribute to Mucosal Immune Homeostasis by Promoting M-Cell Maturation |
| Q43047348 | Evaluation of embryotoxic and embryostatic effects of the aqueous extract of Rhizophora mangle and tannic acid on eggs and larvae of Aedes aegypti |
| Q41581938 | Factors that explain excretion of enteric pathogens by persons without diarrhea |
| Q90574560 | Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition |
| Q36268741 | Functional analysis for gut microbes of the brown tree frog (Polypedates megacephalus) in artificial hibernation |
| Q34103717 | Gastric mucosal defense and cytoprotection |
| Q42910165 | Gene expression of commensal Lactobacillus johnsonii strain NCC533 during in vitro growth and in the murine gut. |
| Q54230553 | Goblet cells and mucin related gene expression in mice infected with Eimeria papillata. |
| Q26822449 | Goblet cells and mucins: role in innate defense in enteric infections |
| Q52690993 | Green tea polyphenols enhance gingival keratinocyte integrity and protect against invasion by Porphyromonas gingivalis. |
| Q29616812 | Gut Microbiota in Health and Disease |
| Q38690823 | Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? |
| Q34499017 | Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease |
| Q35679581 | High Incubation Temperature and Threonine Dietary Level Improve Ileum Response Against Post-Hatch Salmonella Enteritidis Inoculation in Broiler Chicks |
| Q51168071 | Histological alterations and microbial ecology of the intestine in gilthead seabream (Sparus aurata L.) fed dietary probiotics and microalgae. |
| Q38852263 | Host inflammatory response inhibits Escherichia coli O157:H7 adhesion to gut epithelium through augmentation of mucin expression |
| Q35835388 | Host-Microbe Protein Interactions during Bacterial Infection |
| Q37805002 | Host-bacterial symbiosis in health and disease |
| Q38865890 | How the microbiota shapes rheumatic diseases |
| Q26823809 | Human breast milk and the gastrointestinal innate immune system |
| Q37075475 | Human microbiota-secreted factors inhibit shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7. |
| Q36823651 | Identification of commensal Escherichia coli genes involved in biofilm resistance to pathogen colonization |
| Q36594616 | Identification of genes associated with the long-gut-persistence phenotype of the probiotic Lactobacillus johnsonii strain NCC533 using a combination of genomics and transcriptome analysis |
| Q33698781 | Immune activation and HIV persistence: considerations for novel therapeutic interventions |
| Q93140751 | Impact of chronic immobilization stress on parameters of colonic homeostasis in BALB/c mice |
| Q33313625 | Impact of the intestinal microbiota on the development of mucosal defense. |
| Q35270658 | Impairment of swimming motility by antidiarrheic Lactobacillus acidophilus strain LB retards internalization of Salmonella enterica serovar Typhimurium within human enterocyte-like cells |
| Q52606035 | In vivo effects of dietary (1→3), (1→4)-β-D-glucans from oat on mucosal immune responses in man and mice. |
| Q37273387 | Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli |
| Q38756634 | Inflammation-associated DNA methylation patterns in epithelium of ulcerative colitis. |
| Q38013747 | Innate Immunity in the Small Intestine of the Preterm Infant |
| Q34726804 | Innate and acquired immunity in the human penile urethra |
| Q37974695 | Innate host responses to enteric bacterial pathogens: a balancing act between resistance and tolerance. |
| Q35090110 | Interaction of Salmonella spp. with the Intestinal Microbiota |
| Q37186833 | Interactions between commensal bacteria and the gut-associated immune system of the chicken |
| Q37111200 | Interactions of the intestinal epithelium with the pathogen and the indigenous microbiota: a three-way crosstalk |
| Q39314776 | Interleukin 17 is a chief orchestrator of immunity |
| Q33743503 | Intestinal Epithelial Serum Amyloid A Modulates Bacterial Growth In Vitro and Pro-Inflammatory Responses in Mouse Experimental Colitis |
| Q28603596 | Intestinal Epithelial Toll-Like Receptor 4 Signaling Affects Epithelial Function and Colonic Microbiota and Promotes a Risk for Transmissible Colitis |
| Q33431449 | Intestinal barrier function in response to abundant or depleted mucosal glutathione in Salmonella-infected rats |
| Q34102377 | Intestinal goblet cells and mucins in health and disease: recent insights and progress |
| Q42909140 | Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. |
| Q38062446 | Intestinal microbiota, probiotics and human gastrointestinal cancers |
| Q57177121 | Intestinal organoids for modelling intestinal development and disease |
| Q84580466 | Intraepithelial lymphocytes, goblet cells and VIP-IR submucosal neurons of jejunum rats infected with Toxoplasma gondii |
| Q92744367 | Is the colon mucosa affected by ten days of gastric restriction in an animal model? |
| Q39204664 | Lactobacillus casei Zhang modulate cytokine and toll-like receptor expression and beneficially regulate poly I:C-induced immune responses in RAW264.7 macrophages |
| Q42625499 | Lactobacillus fermentum BCS87 expresses mucus- and mucin-binding proteins on the cell surface |
| Q44975860 | Lactobacillus plantarum CS24.2 prevents Escherichia coli adhesion to HT-29 cells and also down-regulates enteropathogen-induced tumor necrosis factor-α and interleukin-8 expression |
| Q34587671 | Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function |
| Q39500680 | Lipid raft-dependent adhesion of Giardia intestinalis trophozoites to a cultured human enterocyte-like Caco-2/TC7 cell monolayer leads to cytoskeleton-dependent functional injuries |
| Q37427798 | Management of the human mucosal defensive barrier: evidence for glycan legislation |
| Q47133700 | Matrix metalloproteinase MMP9 maintains epithelial barrier function and preserves mucosal lining in colitis associated cancer |
| Q39339639 | Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease |
| Q35570413 | Microbial ecology in Hydra: why viruses matter |
| Q35019917 | Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections |
| Q26785532 | Microbiota and the control of blood-tissue barriers |
| Q38049200 | Modern approaches in probiotics research to control foodborne pathogens. |
| Q64228890 | Modulation of Gut Microbiota Composition by Serotonin Signaling Influences Intestinal Immune Response and Susceptibility to Colitis |
| Q35550764 | Modulation of Intestinal Epithelial Defense Responses by Probiotic Bacteria |
| Q37009028 | Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract |
| Q26749210 | Modulatory Effects of Gut Microbiota on the Central Nervous System: How Gut Could Play a Role in Neuropsychiatric Health and Diseases |
| Q42773454 | Molecular aspects of mucin biosynthesis and mucus formation in the bovine cervix during the periestrous period |
| Q36801108 | Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine |
| Q39577860 | Muc17 protects intestinal epithelial cells from enteroinvasive E. coli infection by promoting epithelial barrier integrity |
| Q33582232 | Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa |
| Q34503629 | Mucin-bacterial interactions in the human oral cavity and digestive tract |
| Q37380400 | Mucin-type O-glycans and their roles in intestinal homeostasis |
| Q26863143 | Mucosal Inflammatory Response to Salmonella typhimurium Infection |
| Q41447323 | Mucus organisation is shaped by colonic content; a new view. |
| Q40061673 | Mycobacterium avium subspecies paratuberculosis infects and multiplies in enteric glial cells |
| Q37821275 | Non-invasive assessment of barrier integrity and function of the human gut. |
| Q33980715 | Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in mice |
| Q43508799 | Orally administered ovine serum immunoglobulins modulate the intestinal levels of Lactobacillus and enterobacteria in the growing rat. |
| Q35701455 | Overview of the gastrointestinal microbiota |
| Q39743175 | Parasiticidal activity of human alpha-defensin-5 against Toxoplasma gondii |
| Q39035255 | Pathogenesis of NEC: Role of the innate and adaptive immune response. |
| Q37264192 | Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines |
| Q35757886 | Population structure of gut Escherichia coli and its role in development of extra-intestinal infections |
| Q33905223 | Porcine small intestinal epithelial cell line (IPEC-J2) of rotavirus infection as a new model for the study of innate immune responses to rotaviruses and probiotics |
| Q24651252 | Potential prebiotic properties of almond (Amygdalus communis L.) seeds |
| Q34529060 | Prebiotics to fight diseases: reality or fiction? |
| Q93058507 | Probiotics and their role in gastrointestinal cancers prevention and treatment; an overview |
| Q34637205 | Probiotics in the intensive care unit |
| Q47189424 | Probiotics or Pro-healers the Role of Beneficial Bacteria in Tissue Repair |
| Q38911426 | Protective effects of baicalin on LPS-induced injury in intestinal epithelial cells and intercellular tight junctions |
| Q57122391 | Pulse probiotic administration induces repeated small intestinal Muc3 expression in rats |
| Q98892417 | Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease |
| Q37829145 | Respiratory and gastrointestinal epithelial modulation of the immune response during viral infection. |
| Q37894693 | Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development |
| Q30421083 | Role of Corticotropin-releasing Factor in Gastrointestinal Permeability. |
| Q93054362 | Role of gut microbiota in dog and cat's health and diseases |
| Q41849149 | Role of motility and the flhDC Operon in Escherichia coli MG1655 colonization of the mouse intestine |
| Q36993969 | Role of probiotics in short bowel syndrome in infants and children--a systematic review. |
| Q41358282 | Roles and regulation of the mucus barrier in the gut. |
| Q48011854 | Salmonella serovar-specific interaction with jejunal epithelial cells. |
| Q33579251 | Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects |
| Q24620817 | Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut |
| Q37175693 | Secretory IgA: arresting microbial pathogens at epithelial borders |
| Q30432788 | Selective translocation of the Bordetella pertussis adenylate cyclase toxin across the basolateral membranes of polarized epithelial cells |
| Q92244175 | Social amoebae establish a protective interface with their bacterial associates by lectin agglutination |
| Q27335934 | Species-specific viromes in the ancestral holobiont Hydra |
| Q35171253 | Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial |
| Q37318058 | Ste20-related proline/alanine-rich kinase: a novel regulator of intestinal inflammation |
| Q35102993 | Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer |
| Q33538452 | Systematic approach to optimizing specifically targeted antimicrobial peptides against Streptococcus mutans |
| Q38189500 | Systemic immune activation in HIV and potential therapeutic options. |
| Q21263113 | The PTS transporters of Lactobacillus gasseri ATCC 33323 |
| Q58790555 | The effects of fermentation products of prebiotic fibres on gut barrier and immune functions in vitro |
| Q38426353 | The effects of lactoferrin on the intestinal environment of broiler chickens. |
| Q37798825 | The enteric nervous system as a regulator of intestinal epithelial barrier function in health and disease |
| Q34601452 | The epidemiology and pathogenesis of neoplasia in the small intestine |
| Q50015969 | The expression of adhesin EF-Tu in response to mucin and its role in Lactobacillus adhesion and competitive inhibition of enteropathogens to mucin |
| Q21135552 | The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes |
| Q37848454 | The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept |
| Q33737683 | The human host defense peptide LL-37 interacts with Neisseria meningitidis capsular polysaccharides and inhibits inflammatory mediators release |
| Q38503059 | The intestinal glycome and its modulation by diet and nutrition |
| Q37174716 | The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? |
| Q35802798 | The microbiome at the pulmonary alveolar niche and its role in Mycobacterium tuberculosis infection |
| Q35522722 | The role of the microbiota in ageing: current state and perspectives |
| Q37398270 | The salivary transcriptome of Anopheles gambiae (Diptera: Culicidae) larvae: A microarray-based analysis |
| Q28384040 | Titanium dioxide nanoparticle impact and translocation through ex vivo, in vivo and in vitro gut epithelia |
| Q48366071 | Toxoplasma gondii promotes changes in VIPergic submucosal neurons, mucosal intraepithelial lymphocytes, and goblet cells during acute infection in the ileum of rats. |
| Q35557642 | Transcriptional modulation of intestinal innate defense/inflammation genes by preterm infant microbiota in a humanized gnotobiotic mouse model |
| Q36068446 | Trends in dairy and non-dairy probiotic products - a review |
| Q33676012 | Two atypical enteropathogenic Escherichia coli strains induce the production of secreted and membrane-bound mucins to benefit their own growth at the apical surface of human mucin-secreting intestinal HT29-MTX cells |
| Q26825483 | Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier |
| Q36780412 | Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups |
| Q36375028 | Using unfixed, frozen tissues to study natural mucin distribution |
| Q63213123 | Vaccination Against Fungal Diseases: Lessons from Candida albicans |
| Q28483996 | Vibrio cholerae VexH encodes a multiple drug efflux pump that contributes to the production of cholera toxin and the toxin co-regulated pilus |
| Q42218324 | Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. |
| Q34361733 | Worms need microbes too: microbiota, health and aging in Caenorhabditis elegans |
| Q38219180 | Yacon (Smallanthus sonchifolius): a food with multiple functions |
Search more.